Home Pharmacognosy (PDF) Phytochemical APIs Market – Growing Preferences of Herbal Medicines Over Allopathic Drugs Expected to Drive Market Growth

(PDF) Phytochemical APIs Market – Growing Preferences of Herbal Medicines Over Allopathic Drugs Expected to Drive Market Growth


Phytochemical APIs are active chemicals with therapeutic qualities derived from plants using semi-synthetic techniques. The primary and secondary elements of phytochemicals are divided into two categories. Chlorophyll, protein, sugar, and amino acids are primary phytochemicals, while terpenoids and alkaloids are secondary components. APIs derived from phytochemicals are used by pharmaceutical companies to develop new drugs to treat a variety of diseases.

Download Free PDF Sample: https://www.coherentmarketinsights.com/insight/request-sample/2492

Global Phytochemical API Market Drivers

The phytochemical API market is expected to grow in response to the increasing demand for herbal remedies as compared to allopathic pharmaceuticals. In addition, increased pharmacognosy research efforts to develop drugs incorporating natural chemical components are another driver of the phytochemical API market. For example, in 2017, according to a new research paper published in the Journal of Natural Compounds, the International Cooperative Biodiversity Group discovered a new chemical, Patentiflorin A, derived from Willow-leaved Justicia. Patentiflorin A could inhibit the action of reverse transcriptase much more effectively than azidothymidine (AZT). AZT is an antiretroviral drug used to prevent and treat HIV / AIDS. Patentiflorin A acts as a novel anti-HIV agent which can be used with current anti-HIV drugs to suppress the activity of the HIV virus and prevent AIDS.

The availability of well-known allopathic pharmaceuticals that cure medical conditions in less time than herbal pharmaceuticals is expected to thwart the expansion of the phytochemicals industry of APIs.

Global Phytochemical APIs Market – Regional Analysis

On the basis of region, the global phytochemical API market is segmented into North America, Latin America, Europe, Asia-Pacific, Middle East and Africa.

Due to the increasing number of pipeline studies to create pharmaceuticals using active chemical compounds extracted from plants, the phytochemical API market in North America is expected to experience favorable growth. For example, in August 2018, the University of Michigan initiated a phase 2 / phase 3 clinical trial for colchicine, to study the effect of postoperative colchicine treatment in Fontan’s patients. Colchicine, an anti-inflammatory agent, is a toxic alkaloid and secondary metabolite extracted from plants of the genus Colchicum. The study is expected to be completed by June 2020.

Purchase this Research Study Report with a Discount of US $ 2,000 at https://www.coherentmarketinsights.com/promo/buynow/2492

In addition, leading players in Europe are focusing on business tactics such as acquisitions and collaborations to grow their businesses, with the region’s phytochemical API market expected to grow at a high rate. For example, in 2014, Centroflora CMS, a Luxembourg-based pharmaceutical company, purchased the API range of phytochemicals from Boehringer Ingelheim. Boehringer Ingelheim announced an exclusive multi-year agreement with the company to bring phytochemical APIs to market. Among the products acquired are atropine and atropine sulfate, digoxin and digoxin micron, as well as metildigoxin, homatropin methylbromide, homatropine hydrobromide and dihydroergotamine mesylate.

Major players in the phytochemical API market include Kothari Phytochemicals & Industries Ltd., Lipo Foods, Medipure Pharmaceuticals Inc., Centroflora CMS, SeQuent Scientific Limited, Arboris LLC, Cargill Inc., Indo Phytochem Pharmaceuticals. and BASF SE.

Global Phytochemical API Market Taxonomy

By molecule type

  • Alkaloids
  • Anthocyanins
  • Flavonoids
  • Phenolic acids
  • Terpenoids
  • Lignans and stilbenes
  • Others

By end user

  • Pharmaceutical
  • Nutraceuticals
  • Plant based industries
  • Others

By region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on helping our plethora of clients achieve transformational growth by helping them make critical business decisions. We have our head office in India, an office at Global Financial Capital in the United States, and business consultants in the United Kingdom and Japan. Our clientele includes players from various industries in more than 150 countries around the world. We pride ourselves on serving clients from all walks of life, from Fortune 500 companies to nonprofits and startups looking to gain a foothold in the market. We excel in providing unmatched actionable market insights across various industry verticals including chemicals and materials, healthcare, food and beverage, consumer goods, packaging, semiconductors, software and services, telecommunications and automotive. We offer syndicated market intelligence reports, customized research solutions and advisory services.

To learn more about us, please visit our website – www.coherentmarketinsights.com


Consistent market information
1001 4th Ave, # 3200 Seattle, WA 98154, USA
Email: [email protected]
United States of America: + 1-206-701-6702
United Kingdom: + 44-020-8133-4027
Japan: + 050-5539-1737
India: + 91-848-285-0837


Please enter your comment!
Please enter your name here